Li G, Marchevsky NG, Macaulay G, Aley P, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006). Vaccine 2025;62:127597.
PMID: 40857840